Trial Profile
Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes: A Prospective Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Mar 2023
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary) ; Solifenacin
- Indications Overactive bladder
- Focus Adverse reactions
- 06 Mar 2023 Status changed from recruiting to completed.
- 21 Sep 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 07 Sep 2015 New trial record